Efficacy of the drug Vitalux Plus of patients with dry form of age-related macular degeneration

Efficacy of the drug Vitalux Plus of patients with dry form of age-related macular degeneration

Show other versions (1)

Purpose: To analyze the data, visometry and the thickness of the fovea, patients with dry form of age-related macular degeneration (AMD) after dosing Vitalux Plus.Methods: We observed 25 patients with dry form of AMD. Visometry and optical coherence tomography of the macula was assessed at 1 and 3 m...

Full description

Bibliographic Details
Main Authors:	I. R. Gazizova, Z. F. Kamaltdinova, F. F. Fajzulina
Format:	Article
Language:	Russian
Published:	Ophthalmology Publishing Group 2014-07-01
Series:	Oftalʹmologiâ
Subjects:	возрастная макулярная дегенерация виталюкс плюс оптическая когерентная томография.
Online Access:	https://www.ophthalmojournal.com/opht/article/view/85

Similar Items

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Cataract surgery in patients with age-related macular degeneration: questions and controversies
by: E. I. Dmitrieva, et al.
Published: (2022-03-01)

Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01)

Retinal clinical and morphofunctional changes in high myopia in combination with age-related macular degeneration of different stages
by: L. K. Moshetova, et al.
Published: (2022-09-01)

An integrated analysis of clinical and morphometric indications of atrophic forms of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2022-01-01)

Mixed (combined) phenotype of the late stage of age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-06-01)

The Use of Nutraceuticals in Patients with “Dry” Form of Age-Related Macular Degeneration on the Background of Accelerated Aging
by: S. A. Korotkih, et al.
Published: (2019-06-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01)

The Significance of Screening Questionnaire in the Evaluation of Age-Related Macular Risk Degeneration Development
by: L. A. Kochmasheva, et al.
Published: (2019-12-01)

The Results of Morphometric Assessment of the Macular Zone in Congenital Cataract
by: L. A. Katargina, et al.
Published: (2018-10-01)

The results of diagnostic and treatment of patients with diabetic retinopathy and age-related macular degeneration at a diabetes type 2.
by: I. V. Vorobyova, et al.
Published: (2014-10-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

The role of free-radical processes in the pathogenesis of age-related macular degeneration. Review
by: A. V. Kolesnikov, et al.
Published: (2014-07-01)

Efficiency of Retinoprotective Dry AMD Therapy with Neuroprotective Therapy: a Randomized Clinical Trials Meta-analysis
by: V. P. Erichev, et al.
Published: (2018-03-01)

Epidemiology of Age-Related Macular Degeneration in the Republic of Bashkortostan (Clinical and Statistical Analisys of the “Ural Eye and Medical Study”)
by: T. R. Gilmanshin
Published: (2019-04-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Our Experience of Nutraceutical Effects in Age-Related Macular Degeneration
by: S. V. Yanchenko, et al.
Published: (2020-12-01)

Experiences of treatment of age related macular degeneration with concomitant myopia
by: I. B. Alekseev, et al.
Published: (2019-03-01)

An integrated assessment of ophthalmogeriatric changes in patients with the wet form of agerelated macular degeneration
by: A. Y. Brezhnev, et al.
Published: (2022-06-01)

To the Question of Terminology, Expert Criteria for Evaluating the Effectiveness of Antiangiogenic Therapy and the Prevalence of Refractory Forms of Neovascular Age-Related Macular Degeneration. Review
by: V. G. Likhvantseva, et al.
Published: (2021-10-01)

The complex model of risk and progression of AMD estimation
by: V. S. Akopyan, et al.
Published: (2014-07-01)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Electrophysiological signs of retinal cone remodeling in geographic atrophy of the pigment epithelium in patients with non-exudative age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-09-01)

Myopia and age-related macular degeneration: structural and anatomical changes of the eye
by: I. B. Alekseev, et al.
Published: (2019-08-01)

Efficacy of the drug Vitalux Plus of patients with dry form of age-related macular degeneration
by: I. R. Gazizova, et al.
Published: (2014-07-01)

Evaluation of Flowmetry Indicators in Patients with a Wet AMD Form during Antiangiogenic Therapy
by: N. Yu. Yousef, et al.
Published: (2019-12-01)

Non-Invasive Diagnosis of Polypoidal Choroidal Vasculopathy as a Variant of the Course of Age-Related Macular Degeneration
by: I. E. Panova, et al.
Published: (2018-07-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Determination of the optical density of macular pigment: clinical value
by: M. M. Bikbov, et al.
Published: (2022-03-01)

Nutraceuticals for Age-Related Macular Degeneration: Formulation Optimization Focused on Safety
by: E. K. Pedanova
Published: (2022-04-01)

The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration
by: V. V. Neroev, et al.
Published: (2018-10-01)

Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration
by: D. A. Dorofeev
Published: (2018-10-01)

Combined modality therapy for exsudative form of age-related macular degeneration
by: М. V. Budzinskaya, et al.
Published: (2013-03-01)

Combined modality therapy for exsudative form of age-related macular degeneration
by: М. V. Budzinskaya, et al.
Published: (2013-01-01)

ADVANCED MEDICAL INFORMATION TECHNOLOGY 1.0 PROGRAM APPLICATION IN THE ANALYSIS OF PATIENTS WITH THE AGE-RELATED MACULAR DEGENERATION
by: Ye. V. Melehin, et al.
Published: (2014-02-01)

Study of the Level of Pro- and Antiangiogenic Growth Factors in Vitreous Fluid in Neovascular Age-Related Macular Degeneration on the Background of Treatment
by: M. M. Arkhipova, et al.
Published: (2022-07-01)

Hypermetropia as a Risk Factor for Age-Related Macular Degeneration. Review
by: V. G. Likhvantseva, et al.
Published: (2022-07-01)

Analysis of the Significance of Keratotopography, Keratopachymetry and Optical Coherence Tomography of the Cornea in the Differential Diagnosis of Pellucid Marginal Corneal Degeneration and Keratoconus
by: I. V. Vasilieva, et al.
Published: (2022-10-01)

Small choroidal melanoma and pseudomelanomas: methods of differential diagnostics (literature review). Part 3
by: E. B. Myakoshina
Published: (2020-12-01)